EMBR-13. NOVEL SYNERGISTIC APPROACHES FOR TARGETED THERAPY OF MYC-DRIVEN MEDULLOBLASTOMA USING CRISPR/CAS9 GENE EDITING

INTRODUCTION: Resistance to chemotherapy is a common cause of treatment failure in cancer patients and a major problem facing current cancer research. Targeted modulation of oncogenic signaling pathways may be used to systematically characterize drug resistance mechanisms across tumor entities and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Nan, Picard, Daniel, Rickert, Daniel, Meyer, Frauke-Dorothee, Blümel, Lena, Göbbels, Sarah, Bartl, Jasmin, Pauck, David, Fischer, Ute, Borkhardt, Arndt, Reifenberger, Guido, Remke, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Embryonal Tumors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168144/
http://dx.doi.org/10.1093/neuonc/noab090.031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168144/
http://dx.doi.org/10.1093/neuonc/noab090.031

Ejemplares similares